SLC2A1 and ovarian carcinoma: The expression of several glycolytic enzymes (GLUT1, HK2, and LDHA) and their contribution to the promotion of ovarian cancer were assessed in a study by Xintaropoulou et al. This study also demonstrated that ovarian cancer proliferation and the growth of cells were decreased when the glycolytic cycle was inhibited using several glycolytic inhibitors [41].